Phage display remains the most widely used antibody discovery method owing to its versatility, robustness, applicability, and ...

Uniform protein labeling in intact tissues is a challenge. An approach that allows antibodies to seep within organs could ...

The year 2015 marked the inception of Sanyou Bio's technological journey, laying the foundation for its core technology platform. The R&D team devoted itself to the development of display vectors, ...

In this article, we are going to take a look at where Absci Corporation (NASDAQ:ABSI) stands against the other medical AI ...

Scientists at Stanford are developing a painless, topical vaccine using a common skin bacterium to trigger immunity.

A new technology developed at MIT enables scientists to label proteins across millions of individual cells in fully intact 3D ...

Monoclonal antibodies, or mAbs, are important tools in medicine. These laboratory-made proteins are widely used in treatments ...

Invenra will leverage its B-Body® bispecific antibody platform from monoclonal antibody discovery to optimized panels of bispecific leads. Orion will be responsible for the selection of targets ...

Orion and Invenra announce discovery service and commercial license agreement to develop innovative bispecific antibody cancer therapeutics Orion Corporation ("Orion") and Invenra Inc. ("Invenra ...